Darling Ingredients Q4 EPS $0.96 Misses $1.34 Estimate, Sales $1.77B Beat $1.70B Estimate

Darling Ingredients (NYSE:DAR) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $1.34 by 28.36 percent. This is a 2.13 percent increase over earnings of $0.94 per share from

Darling Ingredients (NYSE:DAR) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $1.34 by 28.36 percent. This is a 2.13 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $1.77 billion which beat the analyst consensus estimate of $1.70 billion by 4.00 percent. This is a 34.97 percent increase over sales of $1.31 billion the same period last year.

Total
0
Shares
Related Posts
Read More

Intercept Pharma Stock Tumbles: FDA Panel Votes Against Intercept’s Fatty Liver Drug, Dashing Its Dreams To Enter NASH Space

FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's (NASDAQ: ICPT) Ocaliva 25 mg, also known as Obeticholic acid (OCA), don't outweigh the risks in nonalcoholic steatohepatitis (NASH) patient

ICPT